Dr. Emily Bergsland, MD
Claim this profileUniversity of California, San Francisco
Area of expertise
Cancer
Emily Bergsland, MD has run 1 trial for Cancer. Some of their research focus areas include:
Neuroendocrine Tumors
Emily Bergsland, MD has run 1 trial for Neuroendocrine Tumors. Some of their research focus areas include:
Affiliated Hospitals
University Of California, San Francisco
Clinical Trials Emily Bergsland, MD is currently running
Lenvatinib + Pembrolizumab
for Neuroendocrine Cancer
This is the first study to be done in a newly described class of neuroendocrine tumors known as well-differentiated grade 3 neuroendocrine tumors (WD G3 NET). First described in the pancreas in 2017, the classification was broadened to include gastrointestinal tract tumors in 2019. Recent data suggest an equivalent subtype exists in the lungs (NEC with carcinoid morphology). WD G3 NETs can occur de novo as well as the result of grade progression over time. This is a single arm, multi-site, Phase II study in biomarker "unselected" participants. This study will also incorporate serial blood samples, tumor biopsies, and special imaging to better understand the impact of therapy on the tumor and microenvironment. Hyperpolarized (HP) 13C-pyruvate magnetic resonance imaging (MRI) - a novel non-radioactive imaging modality able to provide in vivo measurements of the pyruvate-to-lactate conversion rate (kpl).
Recruiting
1 award
Phase 2
Genetic Testing
for Pancreatic Neuroendocrine Tumors
This is a prospective observational multi-center pilot study of germline testing for participants receiving care at University of California participating locations with a new or existing diagnosis of Pancreatic Neuroendocrine Neoplasms (PanNEN). This protocol is an extension of existing Genetic Testing Station efforts at University of California, San Francisco (UCSF)
Recruiting
1 award
N/A
4 criteria
More about Emily Bergsland, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Emily Bergsland, MD has experience with
- Lenvatinib
- Pembrolizumab
- Hereditary Cancer Panel
Breakdown of trials Emily Bergsland, MD has run
Neuroendocrine Tumors
Carcinoid Tumor
Pancreatic Cancer
Pancreatic Neuroendocrine Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Emily Bergsland, MD specialize in?
Emily Bergsland, MD focuses on Cancer and Neuroendocrine Tumors. In particular, much of their work with Cancer has involved Ki67 positive patients, or patients who are Stage III.
Is Emily Bergsland, MD currently recruiting for clinical trials?
Yes, Emily Bergsland, MD is currently recruiting for 2 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Emily Bergsland, MD has studied deeply?
Yes, Emily Bergsland, MD has studied treatments such as Lenvatinib, Pembrolizumab, Hereditary Cancer Panel.
What is the best way to schedule an appointment with Emily Bergsland, MD?
Apply for one of the trials that Emily Bergsland, MD is conducting.
What is the office address of Emily Bergsland, MD?
The office of Emily Bergsland, MD is located at: University of California, San Francisco, San Francisco, California 94143 United States. This is the address for their practice at the University of California, San Francisco.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.